» Articles » PMID: 32947886

Probing the Highly Disparate Dual Inhibitory Mechanisms of Novel Quinazoline Derivatives Against Protein Kinases A and B

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Sep 19
PMID 32947886
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

() serine/threonine (Ser/Thr) Protein kinases A (PknA) and B (PknB) have been identified as highly attractive targets for overcoming drug resistant tuberculosis. A recent lead series optimization study yielded compound which exhibited potencies ~1000 times higher than compound . This huge discrepancy left us curious to investigate the mechanistic 'dual' (in)activities of the compound using computational methods, as carried out in this study. Findings revealed that stabilized the PknA and B conformations and reduced their structural activities relative to . Optimal stability of in the hydrophobic pockets further induced systemic alterations at the P-loops, catalytic loops, helix Cs and DFG motifs of PknA and B. Comparatively, was more surface-bound with highly unstable motions. Furthermore, demonstrated similar binding patterns in PknA and B, involving conserved residues of their binding pockets. Both π and hydrogen interactions played crucial roles in the binding of , which altogether culminated in high Δ for both proteins. On the contrary, the binding of was characterized by unfavorable interactions with possible repulsive effects on its optimal dual binding to both proteins, as evidenced by the relatively lowered Δ. These findings would significantly contribute to the rational structure-based design of novel and highly selective dual inhibitors of PknA and B.

Citing Articles

Polypharmacology-Driven Discovery and Design of Highly Selective, Dual and Multitargeting Inhibitors of - A Review.

Amandy F, Neri G, Manzano J, Go A, Macabeo A Curr Drug Targets. 2024; 25(9):620-634.

PMID: 38859782 DOI: 10.2174/0113894501306302240526160804.

References
1.
Gupta A, Pal S, Pandey D, Fakir N, Rathod S, Sinha D . PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis. Ann Clin Microbiol Antimicrob. 2017; 16(1):56. PMC: 5562987. DOI: 10.1186/s12941-017-0234-9. View

2.
Sittel F, Jain A, Stock G . Principal component analysis of molecular dynamics: on the use of Cartesian vs. internal coordinates. J Chem Phys. 2014; 141(1):014111. DOI: 10.1063/1.4885338. View

3.
Khan M, Kaur P, Nandicoori V . Targeting the messengers: Serine/threonine protein kinases as potential targets for antimycobacterial drug development. IUBMB Life. 2018; 70(9):889-904. DOI: 10.1002/iub.1871. View

4.
Young T, Delagoutte B, Endrizzi J, Falick A, Alber T . Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr protein kinases. Nat Struct Biol. 2003; 10(3):168-74. DOI: 10.1038/nsb897. View

5.
Prisic S, Dankwa S, Schwartz D, Chou M, Locasale J, Kang C . Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases. Proc Natl Acad Sci U S A. 2010; 107(16):7521-6. PMC: 2867705. DOI: 10.1073/pnas.0913482107. View